Acadia Healthcare Company, Inc. $ACHC Stock Sold by Hohimer Wealth Management LLC

Hohimer Wealth Management LLC decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 12.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 213,260 shares of the company’s stock after selling 29,590 shares during the quarter. Hohimer Wealth Management LLC owned approximately 0.23% of Acadia Healthcare worth $5,865,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ACHC. Allworth Financial LP purchased a new stake in Acadia Healthcare during the second quarter valued at about $45,000. Global Retirement Partners LLC bought a new position in Acadia Healthcare during the second quarter worth about $68,000. Integrated Wealth Concepts LLC purchased a new position in shares of Acadia Healthcare in the second quarter worth about $79,000. Quantbot Technologies LP purchased a new position in shares of Acadia Healthcare in the second quarter worth about $88,000. Finally, Pinnacle Wealth Planning Services Inc. raised its position in shares of Acadia Healthcare by 20.7% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company’s stock valued at $88,000 after purchasing an additional 550 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $37.00 on Monday. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $39.38. The business has a 50-day simple moving average of $29.40 and a two-hundred day simple moving average of $26.14. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The company has a market cap of $3.44 billion, a P/E ratio of -2.97, a P/E/G ratio of 10.57 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, November 4th. The company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.14. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.07%. The business had revenue of $895.31 million during the quarter, compared to analyst estimates of $877.76 million. During the same quarter in the previous year, the firm earned $0.72 EPS. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.75 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ACHC has been the topic of a number of recent research reports. KeyCorp upped their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Barclays raised their price objective on shares of Acadia Healthcare from $32.00 to $35.00 and gave the stock an “equal weight” rating in a report on Thursday. Cantor Fitzgerald lifted their price objective on shares of Acadia Healthcare from $30.00 to $39.00 and gave the company a “neutral” rating in a research note on Friday. TD Cowen boosted their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, Leerink Partners increased their target price on Acadia Healthcare from $30.00 to $33.00 and gave the stock a “market perform” rating in a research report on Wednesday, September 23rd. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus price target of $32.54.

Trending Headlines about Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter EPS of $0.60, ahead of the $0.46 consensus, and revenue of $895.3 million, above estimates and up 5.1% year over year. The company also raised its full-year guidance, with its outlook described as slightly above expectations. Article
• Positive Sentiment: Guggenheim raised its target to $41 and kept a Buy rating; RBC lifted its target from $31 to $41 and maintained Outperform. These revisions reinforce optimism about further gains. Article Article
• Neutral Sentiment: Cantor Fitzgerald raised its target to $39 but retained a Neutral rating, signaling a more cautious view than the bullish analyst calls. Analyst rating
• Negative Sentiment: Quarterly EPS was below the $0.72 reported a year earlier. Barclays raised its target to $35 but kept an Equal Weight rating; that target is below the cited current share price, suggesting limited upside in its view. Analyst rating

Acadia Healthcare Profile

Acadia Healthcare Company, Inc is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care.

Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program.

Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.